Literature DB >> 9362017

Risk-sensitive therapeutic strategies for coronary artery disease: toward testing-driven therapy in stable angina patients with low-to-intermediate risk cardiac imaging results.

D D Miller1, B J Gersh.   

Abstract

Entities:  

Mesh:

Year:  1997        PMID: 9362017     DOI: 10.1016/s1071-3581(97)90034-9

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  47 in total

1.  Can we predict future acute coronary events in patients with stable coronary artery disease?

Authors:  J A Ambrose; V Fuster
Journal:  JAMA       Date:  1997 Jan 22-29       Impact factor: 56.272

2.  Cardiac procedures, outcomes, and accountability.

Authors:  H M Krumholz
Journal:  N Engl J Med       Date:  1997-05-22       Impact factor: 91.245

3.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Authors: 
Journal:  JAMA       Date:  1993-06-16       Impact factor: 56.272

4.  Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease.

Authors:  R E Patterson; R L Eisner; S F Horowitz
Journal:  Circulation       Date:  1995-01-01       Impact factor: 29.690

5.  Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease.

Authors:  A S Iskandrian; S C Chae; J Heo; C D Stanberry; V Wasserleben; V Cave
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

6.  Value of the history and physical in identifying patients at increased risk for coronary artery disease.

Authors:  D B Pryor; L Shaw; C B McCants; K L Lee; D B Mark; F E Harrell; L H Muhlbaier; R M Califf
Journal:  Ann Intern Med       Date:  1993-01-15       Impact factor: 25.391

7.  Analysis of coronary angioplasty practice in the United States with an insurance-claims data base.

Authors:  E J Topol; S G Ellis; D M Cosgrove; E R Bates; D W Muller; N J Schork; M A Schork; F D Loop
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

8.  Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial.

Authors:  D Ornish; S E Brown; L W Scherwitz; J H Billings; W T Armstrong; T A Ports; S M McLanahan; R L Kirkeeide; R J Brand; K L Gould
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321

9.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

View more
  2 in total

1.  Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain. Economics of Noninvasive Diagnosis (END) Study Group.

Authors:  L J Shaw; G V Heller; M I Travin; M Lauer; T Marwick; R Hachamovitch; D S Berman; D D Miller
Journal:  J Nucl Cardiol       Date:  1999 Nov-Dec       Impact factor: 5.952

Review 2.  Cost efficiency of nuclear cardiology services in the modern health care environment.

Authors:  D Douglas Miller
Journal:  Curr Cardiol Rep       Date:  2004-01       Impact factor: 2.931

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.